Kazuhiro Takahashi

Professor

Tohoku University graduate school of medicine

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Research Cancer Research professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Kazuhiro Takahashi is a faculty member at Tohoku University Graduate School of Medicine in Japan. His research areas encompass the intersection of medicine and humanity, cancer cell signaling, renal health, and the implications of recent vaccinations on diabetes. He has contributed to notable studies examining the effects of various treatments and diseases, including kidney stone formation and central diabetes insipidus.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (1)

Haruki Fujisawa

Fujita Health University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kazuhiro Takahashi

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Tweets about War, Medicine and Humanity: Do You Hear the People Tweet in Ukraine?

(Pro)renin receptor and insulin signalling regulate cell proliferation in MCF-7 breast cancer cells

Inhibition of sodium-glucose cotransporter 2 suppresses renal stone formation

Inhibition of platelet-derived growth factor pathway suppresses tubulointerstitial injury in renal congestion

Type 1 diabetes mellitus following COVID‐19 RNA‐based vaccine

Studies on anti-rabphilin-3A antibodies in 15 consecutive patients presenting with central diabetes insipidus at a single referral center

Toward the Next 100 Years of the Tohoku Journal of Experimental Medicine

Elevated (Pro)renin Receptor Expression by Anti-Cancer Drugs, Carboplatin and Paclitaxel, in Cultured Cancer Cells: Possible Involvement of Apoptosis and Autophagy

Fulminant Type 1 Diabetes Mellitus Developed about Half a Year after Discontinuation of Immune Checkpoint Inhibitor Combination Therapy with Nivolumab and Ipilimumab: A Case Report

(Pro)renin receptor/ATP6AP2 is required for autophagy and regulates proliferation in lung adenocarcinoma cells

Collaborators (1)

Haruki Fujisawa

Make your next move.